Press Releases

Date	Title	Company
25-Sep-2023	Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach	Adela
25-Sep-2023	palleos healthcare Advances Clinical Trial Execution with Veeva Vault Clinical Data Applications	Veeva Systems
25-Sep-2023	SpineThera SALIENT Clinical Trial Results to Be Presented at Upcoming 22nd Annual ASRA Pain Medicine Meeting	Businesswire
25-Sep-2023	EPKINLY™ (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare as the First Bispecific Antibody to Treat Adults Patients with Certain Types of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)	Businesswire
25-Sep-2023	Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals	Businesswire
25-Sep-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
25-Sep-2023	US FDA approves Jardiance® for the treatment of adults with chronic kidney disease	Eli Lilly
25-Sep-2023	Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults	GSK
25-Sep-2023	Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial	AstraZeneca
25-Sep-2023	MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment	MediLink Therapeutics
25-Sep-2023	Cantourage Group SE: Cantourage shortlisted for European Small and Mid-Cap Awards 2023	Cantourage Group SE
25-Sep-2023	Cellbox Solutions Submits Device Master File (DMF) to the U.S. FDA	Cellbox Solutions
25-Sep-2023	Nano Dentistry Market is expected to 8.12% CAGR by 2033 Simplify Teeth Replacement Procedures and Improve the Osseo integration and Functions of Implants \| FMI	MARKITWIRED
25-Sep-2023	Veterinary Rehabilitation Services Market to Witness A CAGR of 9.06% from 2023 to 2033, Valued at US$ 2.1 Billion \| FMI	MARKITWIRED
25-Sep-2023	Peptide Drug Conjugates Market Predicted to Grow to US$ 5,331.83 Million by 2033: A Promising New Approach to Treating a Wide Range of Diseases \| FMI	MARKITWIRED
25-Sep-2023	Increasing Demand for Sterile Medical Devices and Pharmaceuticals to Drive Terminal Sterilization Services Market is likely to reach US$ 33.5 Billion by 2032 \| FMI	MARKITWIRED
25-Sep-2023	DEFENCE’S ACCUM®-mRNA LIPID NANOPARTICLES ELICIT ANTIBODY RESPONSE 2X STRONGER THAN STANDARD mRNA VACCINES	Defence Therapeutics Inc.
25-Sep-2023	MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications	B3C newswire
25-Sep-2023	Global Pessary Market is expected to reach US$ 831.3 Million by 2032, growing at a CAGR Of 10.2% \| FMI	MARKITWIRED
25-Sep-2023	Intubation Tube Market Aiming to Enable Critical Airways, Anticipates US$ 4.5 Billion by 2032	MARKITWIRED